Highmark Inc-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013439)
◆英語タイトル:Highmark Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013439
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥28,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥56,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥84,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Highmark Inc (Highmark), a subsidiary of Highmark Health, is a provider of healthcare insurance solutions. The company underwrites various indemnities and offers healthcare insurance products to individuals, families, groups, companies and federal employees. In addition, the company provides dental insurance, vision insurance, stop loss insurance and supplemental Medicare products; and process claims for various Medicare members. The company is an independent licensee of Blue Cross and Blue Shield Association. It operates through a network of direct stores, subsidiaries and joint agreements. The company’s key operating areas include Western and Central Pennsylvania; Lehigh valley of Pennsylvania; Delaware; and West Virginia. Highmark is headquartered in Pittsburgh, Pennsylvania, the US.

Highmark Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Highmark Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Highmark Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Highmark Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Highmark Inc, Medical Devices Deals, 2011 to YTD 2017 8
Highmark Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Highmark Inc, Pharmaceuticals & Healthcare, Deal Details 10
Acquisition 10
Highmark Completes Acquisition Of Saint Vincent Health System For US$75 Million 10
Highmark Completes Acquisition Of West Penn Allegheny Health System For US$1.1 Billion 11
Diversified Service Options Completes Acquisition Of Highmark Medicare Services From Highmark 13
Highmark Inc – Key Competitors 14
Highmark Inc – Key Employees 15
Highmark Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Sep 23, 2016: Highmark Health Reports Financial Results Through June 30, 2016 18
Legal and Regulatory 20
May 17, 2016: Highmark Files Suit Against Federal Government Alleging Breaches Of Risk Corridor Obligations Under Patient Protection And Affordable Care Act 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Highmark Inc, Pharmaceuticals & Healthcare, Key Facts 2
Highmark Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Highmark Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Highmark Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Highmark Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Highmark Inc, Medical Devices Deals, 2011 to YTD 2017 8
Highmark Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Highmark Completes Acquisition Of Saint Vincent Health System For US$75 Million 10
Highmark Completes Acquisition Of West Penn Allegheny Health System For US$1.1 Billion 11
Diversified Service Options Completes Acquisition Of Highmark Medicare Services From Highmark 13
Highmark Inc, Key Competitors 14
Highmark Inc, Key Employees 15
Highmark Inc, Subsidiaries 17

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Highmark Inc-製薬・医療分野:企業M&A・提携分析(Highmark Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆